Literature DB >> 22450020

Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis.

J F Gallegos-Orozco1, C D Paskvan-Gawryletz, S R Gurudu, R Orenstein.   

Abstract

Clostridium difficile-associated diarrhea has become one of the most common healthcare-associated infections, with significant morbidity and mortality, especially among the elderly in the inpatient setting. The standard approach with metronidazole and vancomycin is not very effective in treating patients with severe colitis and hence other alternatives have been explored. We herein describe the first successful experience of colonoscopic fecal transplant in a case of severe refractory C. difficile pseudomembranous colitis.

Entities:  

Mesh:

Year:  2012        PMID: 22450020

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  11 in total

1.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

Review 2.  Fecal microbiota transplantation for the management of Clostridium difficile infection.

Authors:  Krishna Rao; Vincent B Young
Journal:  Infect Dis Clin North Am       Date:  2015-03       Impact factor: 5.982

3.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 4.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

5.  Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection.

Authors:  Hadeel Zainah; Mona Hassan; Laila Shiekh-Sroujieh; Syed Hassan; George Alangaden; Mayur Ramesh
Journal:  Dig Dis Sci       Date:  2014-07-23       Impact factor: 3.199

Review 6.  Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology.

Authors:  Alexander Khoruts; Alexa R Weingarden
Journal:  Immunol Lett       Date:  2014-08-10       Impact factor: 3.685

Review 7.  Fecal microbiota transplantation for the treatment of Clostridium difficile infection.

Authors:  Krishna Rao; Nasia Safdar
Journal:  J Hosp Med       Date:  2015-09-07       Impact factor: 2.960

8.  Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Authors:  Shirin Moossavi; Faraz Bishehsari; Reza Ansari; Homayoon Vahedi; Siavosh Nasseri-Moghaddam; Shahin Merat; Iradj Sobhani; Ali Keshavarzian; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2015-07

Review 9.  Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation.

Authors:  Yvette H van Beurden; Max Nieuwdorp; Pablo J E J van de Berg; Chris J J Mulder; Abraham Goorhuis
Journal:  Therap Adv Gastroenterol       Date:  2017-02-08       Impact factor: 4.409

10.  The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.

Authors:  Christine M Akamine; Michael B Ing; Christian S Jackson; Lawrence K Loo
Journal:  BMC Infect Dis       Date:  2016-07-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.